The chemical class of ABHD12 Activators is a conceptual group of compounds that potentially influence the activity of the enzyme ABHD12 (α/β-Hydrolase Domain Containing 12). ABHD12 is primarily known for its role in lipid metabolism, specifically in the hydrolysis of lysophosphatidylserine (LPS), and it has implications in neuroinflammation and neurodegeneration. The activators within this class are characterized by their ability to indirectly affect ABHD12 activity through modulation of lipid metabolism and related signaling pathways. This group includes a variety of compounds like forskolin, resveratrol, and curcumin, which are known to interact with lipid metabolism and inflammatory pathways. Forskolin, for instance, raises cAMP levels, potentially affecting ABHD12 activity by altering signaling pathways associated with lipid metabolism. Resveratrol and curcumin, both possessing properties that influence lipid signaling and inflammation, represent agents that might create a cellular environment conducive to modifying ABHD12 activity. These compounds do not directly target ABHD12; instead, their impact on the enzyme is mediated through their influence on broader metabolic and signaling networks.
Additionally, this class includes PPAR-gamma agonists such as pioglitazone and rosiglitazone, and compounds like omega-3 fatty acids and niacin, all known to affect lipid metabolism. These molecules could indirectly modulate ABHD12 activity by altering the concentration or types of lipid substrates available for the enzyme, or through changes in the lipid metabolic pathways. For example, PPAR-gamma agonists might shift the lipid metabolism balance in a way that influences ABHD12's role in hydrolyzing specific lipid substrates. Similarly, omega-3 fatty acids and niacin, by impacting lipid profiles, could create conditions that affect ABHD12 activity. This indirect mechanism of action underscores the complex nature of enzyme regulation within the cell, where alterations in metabolic pathways can have downstream effects on specific enzymes. The role of these activators is thus significant in understanding the regulatory mechanisms governing lipid metabolism and the potential modulation of enzymes like ABHD12 in response to metabolic changes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, possibly affecting ABHD12 activity by altering lipid metabolism signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to modulate lipid metabolism and inflammation, potentially influencing ABHD12 activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Influences lipid signaling and has anti-inflammatory properties, potentially affecting ABHD | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPAR-gamma agonist, could affect lipid metabolism pathways involving ABHD | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Another PPAR-gamma agonist, might modulate lipid signaling pathways related to ABHD | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Has anti-inflammatory effects and could influence pathways involving ABHD | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Influences lipid metabolism, potentially impacting ABHD12 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Involved in lipid signaling, could potentially influence ABHD | ||||||
Palmitoylethanolamide | 544-31-0 | sc-202754 sc-202754A sc-202754B sc-202754C sc-202754D | 10 mg 50 mg 500 mg 1 g 10 g | $80.00 $243.00 $2091.00 $3339.00 $16657.00 | ||
A fatty acid amide, might influence lipid signaling pathways involving ABHD | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
Another fatty acid amide, could potentially modulate ABHD12 activity through lipid signaling. | ||||||